The risks of using alcohol-based hand sanitiser
Dr Deborah Lee from Dr Fox Online Pharmacy, reveals the risks of using alcohol-based hand sanitiser.
Support health workers with digital health training
Liz Ashall-Payne, Founding CEO of ORCHA, discusses why we must support frontline health workers with world-class digital health training.
Social value in the public & private sector
Peter Masonbrook from Faithful+Gould and Penny Anderson from Atkins discuss the role and importance of social value within the public and private sector.
How data shielded our most vulnerable during the pandemic
Mark Reynolds, Chief Technology Officer at NHS Digital, talks about the unique challenges brought about by the pandemic, and how using data innovatively with the Shielded Patient List and Population Risk Assessment helped to identify and protect some of the most vulnerable in society.
Taking back control to combat COVID misconceptions
Francesca Gargaglia, COO and CBO, Amity, argues that although social media platforms should be responsible for preventing the spread of COVID-19 misinformation, government agencies should build their own communities that build trust and promote well-informed discussions.
FDA approves third Pfizer dose for people with weak immune systems
The US Food and Drug Administration (FDA) have approved a third Pfizer dose for people who are immunocompromised - despite the WHO asking countries to wait until 20% were double-vaccinated, globally.
Moderna create vaccine trial for children aged 6 months and over
Moderna are enrolling roughly 13,275 participants in their vaccine trial for children - with the participants aged between six months to 12 years.
Campaigners call for approval of life saving COVID-19 antibody treatments
A group of patient bodies, charities and senior clinicians have urged the Government to approve the use of life-saving COVID-19 antibody treatments.
Epidemiologist says reaching herd immunity with Delta is “mythical”
Sir Andrew Pollard, head of the Oxford Vaccine Group, said on Tuesday (10 August) that herd immunity is "mythical" in relation to the Delta variant - as it still infects vaccinated individuals.
Self-isolation rules removed for fully vaccinated close contacts
Fully vaccinated individuals will no longer be legally required to self-isolate if they come into contact with a positive COVID-19 case.
COVID-19 booster jab will offer better protection against variants
COVID-19 booster jab will protect people from existing, and potentially future, variants, according to scientists at the University of Nottingham.
Rare case of brain inflammation after mild COVID-19 infection
Physicians at University of California San Diego School of Medicine describe the first known case of a young, healthy adult who suffered brain inflammation after mild COVID-19 infection.
Natural ways to lower your blood pressure
Dr Deborah Lee, Dr Fox Online Pharmacy, tells us about all the way you can naturally lower your blood pressure without medical intervention.
Health innovation is key to resolving challenges faced by the NHS
Lorna Green, Director of Enterprise and Growth, describes the role of the Innovation Agency and the AHSN Network across England and how health innovation is increasingly becoming integral to resolving the long-term challenges faced by the NHS.
Moderna vaccine 93% effective six months after second dose
The Moderna vaccine appears to be 93% effective, six months after the second dose - but CEO Stéphane Bancel says "we must remain vigilant".
Fenofibrate could reduce COVID-19 infection by 70%
According to a new study, fenofibrate, a drug used to treat abnormal levels of fatty substances in the blood, could reduce COVID-19 infection by up to 70%.
NHS says 20% of people hospitalised with COVID are young
New figures from the NHS show that 20% of people hospitalised with COVID right now are young - between the ages of 18 to 34.
Pfizer-BioNTech vaccine to be offered to 16-17-year-olds
The Joint Committee on Vaccination and Immunisation (JCVI) has recommended that all 16 and 17-year-olds should receive their first dose of the Pfizer-BioNTech vaccine.
European commission approves contract for Novavax vaccine
The European Commission has approved a new contract that will allow Member States to purchase up to 100 million doses of the Novavax vaccine.
UK study finds long-term COVID effects rare in children
This UK-based study, published in The Lancet, finds that long-term COVID effects are rare in children - usually, the illness is over after six days.